CME Group (CME) Earns News Sentiment Score of 0.18

News coverage about CME Group (NASDAQ:CME) has trended somewhat positive recently, Accern reports. The research firm identifies negative and positive press coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. CME Group earned a coverage optimism score of 0.18 on Accern’s scale. Accern also gave press coverage about the financial services provider an impact score of 44.9909788308497 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

These are some of the media headlines that may have effected Accern Sentiment’s analysis:

How to Become a New Pot Stock Millionaire

A number of equities research analysts have issued reports on CME shares. BidaskClub cut shares of CME Group from a “buy” rating to a “hold” rating in a report on Tuesday, December 19th. Zacks Investment Research cut shares of CME Group from a “buy” rating to a “hold” rating in a report on Tuesday, March 6th. Berenberg Bank started coverage on shares of CME Group in a report on Thursday, January 25th. They set a “hold” rating and a $170.00 target price on the stock. ValuEngine raised shares of CME Group from a “hold” rating to a “buy” rating in a report on Monday, April 2nd. Finally, Goldman Sachs raised shares of CME Group from a “neutral” rating to a “buy” rating and set a $180.00 target price on the stock in a report on Wednesday, February 7th. Three investment analysts have rated the stock with a hold rating, eleven have given a buy rating and one has given a strong buy rating to the company’s stock. CME Group currently has an average rating of “Buy” and an average target price of $163.69.

Shares of CME Group stock traded down $4.73 during trading on Friday, hitting $158.26. The stock had a trading volume of 1,313,788 shares, compared to its average volume of 2,112,036. The stock has a market cap of $55,479.36, a P/E ratio of 33.18, a PEG ratio of 2.25 and a beta of 0.56. CME Group has a 12 month low of $114.82 and a 12 month high of $171.71. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.03 and a current ratio of 1.03.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Thursday, February 1st. The financial services provider reported $1.12 earnings per share for the quarter, topping the consensus estimate of $1.10 by $0.02. The firm had revenue of $900.00 million for the quarter, compared to analysts’ expectations of $886.85 million. CME Group had a net margin of 111.49% and a return on equity of 7.68%. The business’s quarterly revenue was down 1.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.14 earnings per share. sell-side analysts predict that CME Group will post 6.89 earnings per share for the current year.

The company also recently declared a quarterly dividend, which was paid on Monday, March 26th. Stockholders of record on Friday, March 9th were issued a $0.70 dividend. The ex-dividend date was Thursday, March 8th. This represents a $2.80 annualized dividend and a dividend yield of 1.77%. This is a boost from CME Group’s previous quarterly dividend of $0.66. CME Group’s dividend payout ratio is presently 58.70%.

In related news, Director Ronald A. Pankau sold 200 shares of the company’s stock in a transaction on Wednesday, February 14th. The shares were sold at an average price of $159.91, for a total value of $31,982.00. Following the completion of the transaction, the director now directly owns 3,809 shares in the company, valued at $609,097.19. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Hilda Harris Piell sold 3,299 shares of the company’s stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $163.52, for a total transaction of $539,452.48. The disclosure for this sale can be found here. In the last ninety days, insiders sold 40,699 shares of company stock worth $6,266,062. Insiders own 0.57% of the company’s stock.

TRADEMARK VIOLATION WARNING: “CME Group (CME) Earns News Sentiment Score of 0.18” was first published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this story on another website, it was illegally copied and reposted in violation of United States & international trademark & copyright legislation. The original version of this story can be accessed at https://www.dispatchtribunal.com/2018/04/07/cme-group-cme-earns-news-sentiment-score-of-0-18.html.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.

Insider Buying and Selling by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply